Fund Holdings — Essex Woodlands Management, Inc.

Total Portfolio Value
$344.80M
Total Bought
$752.6K
Total Sold
$23.24M
Net Transaction
-$22.49M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
VENUS CONCEPT, INC.01,089,190+1,089,19007530.22%+753
MEDICINOVA INC(MNOV)1,105,9411,105,94101,6591,6040.47%-55
BIOVENTUS(BVS)13,021,32413,021,324068,62267,71119.64%-911
VENUS CONCEPT, INC.1,089,1900-1,089,1901,2850—-1,285
REVANCE THERAPEUTICS INC457,085457,08504,0182,2490.65%-1,769
TELA BIO, INC.(TELA)4,110,7094,110,709027,21323,3086.76%-3,905
EYEPOINT PHARMACEUTICALS INC(EYPT)2,337,7861,551,521-786,26554,02632,0709.30%-21,956
MIMEDX GROUP, INC.(MDXG)28,195,24928,195,2490247,272217,10362.97%-30,169
Page 1 of 1
Essex Woodlands Management, Inc. — 13F Holdings — Q1 2024 | TickerTrail